Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $71,088 | 36 | 84.5% |
| Food and Beverage | $11,243 | 446 | 13.4% |
| Travel and Lodging | $1,232 | 6 | 1.5% |
| Consulting Fee | $334.00 | 1 | 0.4% |
| Education | $224.03 | 5 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $36,488 | 132 | $0 (2021) |
| Amgen Inc. | $35,811 | 98 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $7,593 | 61 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $893.29 | 43 | $0 (2021) |
| PFIZER INC. | $601.65 | 40 | $0 (2020) |
| Medtronic Vascular, Inc. | $445.09 | 7 | $0 (2020) |
| Amarin Pharma Inc. | $434.52 | 24 | $0 (2021) |
| Astellas Pharma US Inc | $291.11 | 6 | $0 (2021) |
| Boston Scientific Corporation | $272.46 | 11 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $253.85 | 17 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $956.22 | 46 | Janssen Pharmaceuticals, Inc ($142.32) |
| 2020 | $6,017 | 85 | Amgen Inc. ($4,460) |
| 2019 | $19,683 | 108 | Amgen Inc. ($9,277) |
| 2018 | $29,916 | 130 | Amgen Inc. ($15,201) |
| 2017 | $27,548 | 125 | Janssen Pharmaceuticals, Inc ($13,164) |
All Payment Transactions
494 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/10/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/10/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $5.54 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/03/2021 | Medtronic, Inc. | Micra (Device) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Pacemakers | ||||||
| 06/02/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: DIABETES | ||||||
| 05/25/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Cardiovascular | ||||||
| 05/20/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Cardiology | ||||||
| 05/19/2021 | Astellas Pharma US Inc | LEXISCAN (Drug) | Food and Beverage | In-kind items and services | $28.61 | General |
| Category: HOSPITAL AND TRANSPLANT | ||||||
| 05/18/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: DIABETES | ||||||
| 05/12/2021 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Iron Deficiency Anemia | ||||||
| 05/12/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/05/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/28/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: Cardiology | ||||||
| 04/27/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/26/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: DIABETES | ||||||
| 04/20/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/14/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $15.34 | General |
| Category: Cardiovascular | ||||||
| 04/08/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Cardiology | ||||||
| 04/05/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.20 | General |
| Category: Cardiovascular | ||||||
| 03/31/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/30/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/25/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 03/24/2021 | Medtronic, Inc. | Reveal LINQ (Device) | Food and Beverage | In-kind items and services | $98.18 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 03/23/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Cardiovascular | ||||||
| 03/23/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Cardiology | ||||||
| 03/19/2021 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: Iron Deficiency Anemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 15 | 1,026 | 1,195 | $240,165 | $88,706 |
| 2020 | 22 | 1,802 | 2,484 | $492,283 | $183,360 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 294 | 324 | $62,532 | $27,781 | 44.4% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 123 | 124 | $71,052 | $19,463 | 27.4% |
| 78452 | Nuclear medicine study of vessels of heart using drugs or exercise multiple studies | Office | 2021 | 33 | 33 | $33,000 | $12,681 | 38.4% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2021 | 32 | 64 | $8,448 | $6,362 | 75.3% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2021 | 24 | 96 | $7,680 | $4,330 | 56.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 36 | 43 | $7,525 | $3,930 | 52.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 284 | 300 | $13,200 | $3,148 | 23.8% |
| 93880 | Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | Office | 2021 | 24 | 24 | $7,968 | $3,078 | 38.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 17 | 17 | $6,324 | $2,981 | 47.1% |
| 93015 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report | Office | 2021 | 41 | 44 | $15,400 | $2,478 | 16.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 17 | 18 | $1,350 | $1,044 | 77.3% |
| 93227 | Heart rhythm tracing, analysis, and interpretation of 48-hour ekg | Office | 2021 | 32 | 35 | $2,065 | $508.98 | 24.6% |
| 93225 | Heart rhythm tracing of 48-hour ekg | Office | 2021 | 32 | 35 | $2,695 | $507.16 | 18.8% |
| 99407 | Smoking and tobacco use intensive counseling, greater than 10 minutes | Office | 2021 | 13 | 14 | $910.00 | $403.34 | 44.3% |
| J0280 | Injection, aminophyllin, up to 250 mg | Office | 2021 | 24 | 24 | $15.60 | $12.48 | 80.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 420 | 634 | $122,362 | $49,994 | 40.9% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2020 | 212 | 222 | $127,206 | $35,906 | 28.2% |
| 78452 | Nuclear medicine study of vessels of heart using drugs or exercise multiple studies | Office | 2020 | 75 | 76 | $76,000 | $28,634 | 37.7% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2020 | 74 | 150 | $19,800 | $14,123 | 71.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 98 | 124 | $17,605 | $10,066 | 57.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 421 | 621 | $27,324 | $8,136 | 29.8% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2020 | 40 | 164 | $13,120 | $7,282 | 55.5% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 46 | 46 | $17,112 | $7,053 | 41.2% |
| 93880 | Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | Office | 2020 | 42 | 43 | $14,276 | $5,251 | 36.8% |
| 93015 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report | Office | 2020 | 81 | 88 | $30,800 | $4,958 | 16.1% |
About Dr. Ara Sadaniantz, MD
Dr. Ara Sadaniantz, MD is a Cardiovascular Disease healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992766679.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ara Sadaniantz, MD has received a total of $84,120 in payments from pharmaceutical and medical device companies, with $956.22 received in 2021. These payments were reported across 494 transactions from 24 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($71,088).
As a Medicare-enrolled provider, Sadaniantz has provided services to 2,828 Medicare beneficiaries, totaling 3,679 services with total Medicare billing of $272,067. Data is available for 2 years (2020–2021), covering 37 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Providence, RI
- Active Since 03/31/2006
- Last Updated 02/03/2009
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1992766679
Products in Payments
- XARELTO (Drug) $36,488
- Repatha (Biological) $34,898
- PRADAXA (Drug) $7,049
- ELIQUIS (Drug) $1,046
- Corlanor (Drug) $913.28
- JARDIANCE (Drug) $523.17
- Vascepa (Drug) $434.52
- CHANTIX (Drug) $433.71
- WATCHMAN (Device) $272.46
- Reveal LINQ (Device) $268.46
- ENTRESTO (Drug) $216.18
- BRILINTA (Drug) $185.97
- Micra (Device) $139.09
- Livalo (Drug) $135.41
- Visia AF (Device) $100.45
- PRALUENT (Drug) $93.99
- PRALUENT (Biological) $74.47
- NEXLETOL (Drug) $71.76
- FARXIGA (Drug) $67.88
- INJECTAFER (Drug) $66.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Providence
Mrs. Jinnette Abbott, Md, MD
Cardiovascular Disease — Payments: $153,138
John Cava, Md, MD
Cardiovascular Disease — Payments: $57,223
Dr. Carlos Cuello
Cardiovascular Disease — Payments: $19,646
Dr. Franklin Schneider, Md, MD
Cardiovascular Disease — Payments: $15,467
Jeremy Lum, Md, MD
Cardiovascular Disease — Payments: $12,810
Paul Gordon, Md, MD
Cardiovascular Disease — Payments: $12,436